Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies

被引：0
|
作者：
Lo Nigro, Luca [1 ]
机构：
[1] Azienda Policlin G Rodol San Marco, Ctr Pediat Hematol Oncol, Head Cytogenet Cytofluorimetr Mol Biol Lab, Catania, Italy
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
mTOR - mammalian target of rapamycin; acute leukemias; PTEN (phosphatase and tensin homolog deleted on chromosome 10); Rapalogs; PI3; K/AKT;
D O I：
10.3389/fonc.2023.1293795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting the PI3K/mTOR pathway hematologic malignancies
    Tasian, Sarah K.
    Teachey, David T.
    Rheingold, Susan R.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [2] Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
    Wobus, Manja
    Bornhaeuser, Martin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Targeting the apoptosis pathway in hematologic malignancies
    Zaman, Shadia
    Wang, Rui
    Gandhi, Varsha
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 1980 - 1992
  • [4] Targeting the Ras pathway in pediatric hematologic malignancies
    Pikman, Yana
    Stieglitz, Elliot
    CURRENT OPINION IN PEDIATRICS, 2021, 33 (01) : 49 - 58
  • [5] Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
    K Brinkmann
    H Kashkar
    Cell Death & Disease, 2014, 5 : e1098 - e1098
  • [6] Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
    Brinkmann, K.
    Kashkar, H.
    CELL DEATH & DISEASE, 2014, 5 : e1098 - e1098
  • [7] Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies
    Jabbour, Elias
    Ottmann, Oliver G.
    Deininger, Michael
    Hochhaus, Andreas
    HAEMATOLOGICA, 2014, 99 (01) : 7 - 18
  • [8] Utility of mTOR Inhibition in Hematologic Malignancies
    Younes, Anas
    Samad, Nousheen
    ONCOLOGIST, 2011, 16 (06): : 730 - 741
  • [9] mTOR Regulation of Metabolism in Hematologic Malignancies
    Mirabilii, Simone
    Ricciardi, Maria Rosaria
    Tafuri, Agostino
    CELLS, 2020, 9 (02)
  • [10] Editorial commentary - Hematologic malignancies
    Gilliland, DG
    CURRENT OPINION IN HEMATOLOGY, 2001, 8 (04) : 189 - 191
12345